In response to the COVID-19 pandemic, most workplaces have prioritized the implementation of protocols that reduce germ transmission and are guided by infection prevention practices in medical settings. Although many of these practices are now common – washing and sanitizing hands, wearing masks, and physical distancing – most companies could also benefit from a key hospital strategy that addresses a critical source of infection: the nose. When considering disease transmission in the workplace during and beyond the pandemic, are you addressing the germs in the nose?
During this webinar, medical experts will inform attendees of the importance of nasal sanitization – a proven infection prevention measure used by hospitals that can be easily applied to the workplace setting as well.
Key topics of this webinar:
A Q&A session with infection prevention experts will take place at the end of the webinar – bring your questions!
Sue Barnes, RN, CIC, FAPIC, National Infection Prevention and Control Specialist
With more than 30 years of experience in the field of infection prevention, Sue serves as an advisor and consultant for select industry partners and has provided consultative assistance to numerous professional organizations, including the Association for Professionals in Infection Control and Epidemiology, the Association of PeriOperative Registered Nurses, and the Infectious Diseases Society of America. She previously served as the national infection prevention director for Kaiser Permanente for 27 years before retiring in 2016. Sue has helped develop a number of infection prevention guides for APIC and has published numerous articles.
Ron W. Singer, MD, FAOOS, Orthopedic Surgeon
Ron is an orthopedic surgeon who has devoted his career to refining and teaching surgeons across the world safe surgical procedures and new techniques for the benefit of patients. He practices general orthopedics, joint replacements and sports medicine at OrthoCarolina – one of the largest, most comprehensive orthopedic practices in the nation. He’s also the founder and chair of The Surgery Center at Edgewater, a high-quality outpatient surgery care center in South Carolina that he helped develop from the ground up.
Michael J. Manyak, MD, Chief medical advisor for crisis response
Michael is an explorer, author, urologist and corporate medical executive. He serves as the chief medical advisor for crisis response and travel medicine for multiple Fortune 100 companies and for the Greater Washington Board of Trade. Michael is an adjunct professor of urology and engineering and chair of the Department of Urology at George Washington University, member of the Baylor College of Medicine National School of Tropical Medicine, and board member and the vice chair of the HOSA 100 National Advisory Council. He has published more than 250 professional abstracts, book chapters and refereed journal articles.
Ernst Wm. Spannhake, Ph.D., Chief Science Officer for Global Life Technologies Corp.
Bill leads laboratory and clinical research and development at the medical technology company and maker of Nozin-branded Nasal Sanitizer products. Before joining GLTC, Bill served as a professor at the Johns Hopkins University School of Public Health for more than 35 years. He has authored more than 100 scientific articles and chapters, and has studied the microbiome of the anterior nares (skin inside the nostrils) and its role in hospital-acquired infection risk. He retains his affiliation with Johns Hopkins as professor emeritus.
Barry Bottino, Associate Editor, Safety+Health magazine
Barry covers worker safety for Safety+Health.